Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR number # NO-1577272925-2015001473) on 28-DEC-2015. Case received from a other health professional via a health authority on 23-DEC-2015 under the reference number NO-NOMAADVRE-FHI-2015-21217. A 13-year-old female adolescent patient received GARDASIL, (batch number unknown) via parenteral route in NOV-2015. The patient experienced Muscular weakness on 08-DEC-2015, Neurogenic bladder on 08-DEC-2015, Urinary tract infection on an unknown date, Paresis on 07-DEC-2015 and Spinal cord infarction on 07-DEC-2015. Additional investigations included: Varicella Virus Test in Dec-2015: PCR, DNA positive in serum. Nuclear Magnetic Resonance Imaging in Dec-2015: changes in medulla spinalis from C5 to TH1/TH2. The reporter assessed the causal relationship: between Lower extremities weakness of and GARDASIL as Reasonable Possibility; between Bladder paralysis and GARDASIL as Reasonable Possibility; between Urinary tract infection and GARDASIL as Reasonable Possibility; between Paresis in arms and GARDASIL as Reasonable Possibility; between Spinal cord infarction and GARDASIL as Reasonable Possibility.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166